UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004538
Receipt number R000005422
Scientific Title Study of the relationship between analgesic effect buprenorphine and genetic polymorphism of OPRM1
Date of disclosure of the study information 2010/11/10
Last modified on 2011/01/08 19:09:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the relationship between analgesic effect buprenorphine and genetic polymorphism of OPRM1

Acronym

Study of the relationship between analgesic effect buprenorphine and genetic polymorphism of OPRM1

Scientific Title

Study of the relationship between analgesic effect buprenorphine and genetic polymorphism of OPRM1

Scientific Title:Acronym

Study of the relationship between analgesic effect buprenorphine and genetic polymorphism of OPRM1

Region

Japan


Condition

Condition

healthy volunteer

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

to research the relationship between genetic polymorphism of OPRM1 and effect of buprenorphine

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

pain threshold

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

administration of buprenorphine

Interventions/Control_2

administration of buprenorphine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male

Key inclusion criteria

BMI: 18kg/m2<, <26kg/m2
capable of understanding and adhering to the protocol
genotype of OPRM1: 118AA or 118GG

Key exclusion criteria

liver dysfunction
renal dysfunction
ECG abnormality
drug dependence
drug allergy

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiromitsu Imai

Organization

Oita University, Faculty of medicine

Division name

Dept of clinical pharmacology and therapeutics

Zip code


Address

1-1 Idaigaoka Hasama Yufu-city, Oita, JAPAN

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Oita university, Faculty of medicine

Division name

Dept of clinical pharmacology and therapeutics

Zip code


Address


TEL


Homepage URL


Email

imaih@oita-u.ac.jp


Sponsor or person

Institute

Oita University, Faculty of medicine
Dept of clin pharmacol & ther

Institute

Department

Personal name



Funding Source

Organization

research grant for scientific research of MEXT

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 06 Month 30 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 11 Month 10 Day

Last modified on

2011 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005422


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name